Compare Japan Medical Dynamic Marketing, Inc. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
JPY 13,450 Million (Small Cap)
11.00
NA
0.00%
0.09
3.65%
0.55
Revenue and Profits:
Net Sales:
6,318 Million
(Quarterly Results - Dec 2025)
Net Profit:
224 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
44.54%
0%
44.54%
6 Months
30.06%
0%
30.06%
1 Year
16.81%
0%
16.81%
2 Years
-4.71%
0%
-4.71%
3 Years
-32.62%
0%
-32.62%
4 Years
-56.62%
0%
-56.62%
5 Years
-63.85%
0%
-63.85%
Japan Medical Dynamic Marketing, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
6.79%
EBIT Growth (5y)
-10.07%
EBIT to Interest (avg)
50.24
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.87
Tax Ratio
36.99%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.34%
ROE (avg)
7.30%
Valuation key factors
Factor
Value
P/E Ratio
11
Industry P/E
Price to Book Value
0.60
EV to EBIT
9.54
EV to EBITDA
4.60
EV to Capital Employed
0.60
EV to Sales
0.59
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
6.28%
ROE (Latest)
5.31%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
6,318.30
5,690.40
11.03%
Operating Profit (PBDIT) excl Other Income
713.40
452.40
57.69%
Interest
53.40
48.70
9.65%
Exceptional Items
-0.10
-7.70
98.70%
Consolidate Net Profit
223.80
6.50
3,343.08%
Operating Profit Margin (Excl OI)
49.10%
10.10%
3.90%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 11.03% vs -3.88% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is 3,343.08% vs -90.54% in Sep 2025
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
25,114.00
23,177.70
8.35%
Operating Profit (PBDIT) excl Other Income
3,227.40
3,342.10
-3.43%
Interest
75.30
41.30
82.32%
Exceptional Items
-1,778.40
-155.60
-1,042.93%
Consolidate Net Profit
-469.10
1,305.50
-135.93%
Operating Profit Margin (Excl OI)
62.00%
75.40%
-1.34%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is 8.35% vs 8.78% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is -135.93% vs -9.07% in Mar 2024
About Japan Medical Dynamic Marketing, Inc. 
Japan Medical Dynamic Marketing, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






